ÂÜÀòÂÒÂ×

Mark Nibbe is a seasoned accounting professional with extensive experience in cost accounting, financial analysis, and reporting across various companies, including Halozyme Therapeutics, Takeda, and Surmodics. Mark currently serves as a Senior Cost Accountant at Halozyme Therapeutics / Antares Pharma, responsible for inventory accounting, material standard costs, and analysis of purchase price variances. Previous roles encompass managing operations cost accounting at Takeda, where Mark implemented costing functions for a start-up biologics plant, and serving as a Principal Cost Accountant at Surmodics, enhancing product cost accuracy. Mark's early career includes significant contributions in financial analysis and reporting, fixed asset accounting, audit functions, and tax duties at Perrigo Company plc, Paddock Laboratories, Thermotech, Inc., and Menasha Corporation. Mark earned a Bachelor of Science degree in Accounting from Winona State University.